×
Hero Background

Chondroplasty Companies

ID: MRFR/Pharma/2861-HCR
80 Pages
Kinjoll Dey
October 2025

Chondroplasty is a surgical procedure involving the repair or reshaping of damaged cartilage, typically in the joints. Companies involved in the development and manufacturing of products related to chondroplasty may provide a range of solutions, including surgical instruments, implants, and technologies aimed at addressing cartilage-related issues. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Chondroplasty Market Research Report- Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Chondroplasty Market

Chondroplasty Key Companies

 

Latest Chondroplasty Companies Update


Arthrex® Carticel® Autologous Chondrocyte Implant System In September 2023, Arthrex received FDA approval for its Carticel® Autologous Chondrocyte Implant System, an improved version of its existing cartilage repair technology. This system features optimized cell expansion and implantation techniques, potentially leading to better clinical outcomes.


Conventus Orthopaedics' Magellan Autologous Chondrocyte Implant System launched its Magellan Autologous Chondrocyte Implant System in Europe in June 2023. This system offers a cost-effective and user-friendly approach to cartilage repair, potentially widening access to this treatment option.


List of Chondroplasty Key Companies in the Market



  • Braun Melsungen AG

  • NuOrtho Surgical Inc.

  • Zimmer Biomet Holdings Inc.

  • Smith & Nephew plc

  • Nebula Inc.

  • Gpcmedical

  • Osiris Therapeutics Inc.

  • Sklar Surgical Instruments

  • Stryker Corporation


Related Reports

No regional reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035